Evidence map›Paper›PMID 34151070›Full record

ArticleACS omega2021

Stabilization of an

Shino Manabe, Hiroki Takashima, Kazunobu Ohnuki, Yoshikatsu Koga, Ryo Tsumura, Nozomi Iwata, Yang Wang, Takuya Yokokita, Yukiko Komori, Sachiko Usuda and 5 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Tumor Targeting ofMolecular pharmaceutics · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Shino ManabePharmaceutical Department, Hoshi University 2-4-41, Ebara, Shinagawa, Tokyo 142-8501, Japan.ORCID https://orcid.org/0000-0002-2763-1414
Hiroki TakashimaDivision of Developmental Therapeutics, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, 6-5-1 Kahiwanoha, Kashiwa City 277-8577, Japan.
Kazunobu OhnukiDivision of Functional Imaging, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, 6-5-1 Kahiwanoha, Kashiwa City 277-8577, Japan.
Yoshikatsu KogaDivision of Developmental Therapeutics, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, 6-5-1 Kahiwanoha, Kashiwa City 277-8577, Japan.
Ryo TsumuraDivision of Developmental Therapeutics, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, 6-5-1 Kahiwanoha, Kashiwa City 277-8577, Japan.
Nozomi IwataDivision of Developmental Therapeutics, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, 6-5-1 Kahiwanoha, Kashiwa City 277-8577, Japan.
Yang WangNishina Center for Accelerator-Based Science, RIKEN, Hirosawa, Wako-shi, Saitama 351-0198 Japan.
Takuya YokokitaNishina Center for Accelerator-Based Science, RIKEN, Hirosawa, Wako-shi, Saitama 351-0198 Japan.
Yukiko KomoriNishina Center for Accelerator-Based Science, RIKEN, Hirosawa, Wako-shi, Saitama 351-0198 Japan.
Sachiko UsudaNishina Center for Accelerator-Based Science, RIKEN, Hirosawa, Wako-shi, Saitama 351-0198 Japan.
Daiki MoriNishina Center for Accelerator-Based Science, RIKEN, Hirosawa, Wako-shi, Saitama 351-0198 Japan.
Hiromitsu HabaNishina Center for Accelerator-Based Science, RIKEN, Hirosawa, Wako-shi, Saitama 351-0198 Japan.
Hirofumi FujiiDivision of Functional Imaging, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, 6-5-1 Kahiwanoha, Kashiwa City 277-8577, Japan.
Masahiro YasunagaDivision of Developmental Therapeutics, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, 6-5-1 Kahiwanoha, Kashiwa City 277-8577, Japan.
Yasuhiro MatsumuraDepartment of Immune Medicine, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, 104-0045 Tokyo, Japan.
National Cancer Center Hospital East · JPRIKEN Nishina Center · JPTohoku University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34151070
PMCPMC8209801
OpenAlexW3166883356

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.